Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Melbourne N.
Clinical trial register · Australia

Clinical Trials in Melbourne N., 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Melbourne N.

8 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
A Study of [177Lu]Lu-A9-0631 and [225Ac]Ac-A9-0642 With [68Ga]Ga-A9-6217 or [177Lu]Lu-A9-0631 Imaging in GRPR+ Solid Tumors
NCT07661641Breast Cancer, Prostate Cancer, Colorectal Cancer, GRPR-positive Solid Tumors
Alpha-9 Oncology USA Inc.
Phase 1
115
Melbourne N., Murdoch
2026-07-01
Recruiting
Yarrow Bioscience, Inc.
Phase 2
232
East Melbourne, Melbourne N.
2026-06-10
Recruiting
A Gaucher Disease Gene Therapy Trial With FLT201
NCT07223944Gaucher Disease Type 1
Spur Therapeutics
Phase 3
45
Melbourne N.
2026-04-07
Recruiting
Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC
NCT07197580ccRCC, Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC), Renal Cell Cancer Metastatic
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3
40
Sydney, Wollongong, Heidelberg, Melbourne N., Murdoch
2026-03-25
Recruiting
Akyva First In Human
NCT06956209Underactive Bladder
Iota Biosciences, Inc
Not applicable
15
Woolloongabba, Melbourne N.
2025-09-24
Recruiting
PSMA PET Combined With MRI for the Detection of PCa
NCT07052214PCA, Prostate Cancer, Prostatic Neoplasm, PSMA PET
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3
338
Melbourne N., Sydney
2025-08-18
Recruiting
SURGE Therapeutics
Phase 1
18
Melbourne N.
2025-05-08
Recruiting
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
NCT04996875Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Neoplasm (SM-AHN), Mast Cell Leukemia (MCL), Aggressive Systemic Mastocytosis (ASM)
Cogent Biosciences, Inc.
Phase 2
140
Kingswood, Southport, Melbourne N.
2021-11-09
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/melbourne-n

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies with a site in Melbourne N..

How many clinical trials are recruiting in Melbourne N.?

8 of the 8 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Melbourne N.), 8 studies
PhaseStudiesRecruitingShare
Phase 33337.5%
Phase 12225%
Phase 22225%
Not applicable1112.5%

Most active sponsors

Lead sponsors with the most studies (Melbourne N.)
Lead sponsorStudiesRecruiting
Telix Pharmaceuticals (Innovations) Pty Limited22
Alpha-9 Oncology USA Inc.11
Cogent Biosciences, Inc.11
Iota Biosciences, Inc11
Spur Therapeutics11
SURGE Therapeutics11
Yarrow Bioscience, Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.